ABSTRACT
BACKGROUND: Zinc oxide nanoparticles (ZnO-NPs) are currently employed in various products such as rubber, paint, and cosmetics. Our group reported recently that Nrf2 protein provides protection against pulmonary inflammation induced by ZnO-NPs in male mice. The current study investigated the effect of Nrf2 deletion on the lung inflammatory response in female mice exposed to ZnO-NPs. METHODS: An equal number of female Nrf2-/- mice and female Nrf2+/+ mice (24 each) were allocated into three equal groups, and each was exposed to ZnO-NPs at either 0, 10 or 30 µg ZnO-NPs/mouse through pharyngeal aspiration. Bronchoalveolar lavage fluid (BALF) and lungs were examined 14 days later to determine the number of inflammatory cells, the protein level, and for scoring inflammation histopathologically. The mRNA levels of Nrf2-dependent antioxidant enzymes and proinflammatory cytokine in lung tissue were also measured. RESULTS: Exposure to ZnO-NPs increased all types of BALF cells and lung inflammation scores in both of female Nrf2-null (Nrf2-/-) and wild-type (Nrf2+/+) mice, and Nrf2 deletion enhanced ZnO-NPs-induced increase in the number of eosinophils in BALF. Exposure to ZnO-NPs dose-dependently increased the level of oxidized glutathione (GSSG), and mRNA levels of proinflammatory cytokines/chemokines; KC, MIP-2, IL-6, IL-1ß and MCP-1 only in wild-type mice. Nrf2 deletion decreased total glutathione levels and basal mRNA levels of SOD1 and NQO1, and increased the basal mRNA level of above proinflammatory cytokines/chemokines. Nrf2 deletion enhanced ZnO-NPs-induced downregulation of GcLc, GR and TGF-ß and upregulation of HO-1 and TNF-α. Taken together with our previous results in male mice, our results showed a lower susceptibility of females to lung tissue inflammation, relative to males, irrespective of Nrf2 deletion, and that enhancement of ZnO-NPs-induced upregulation of HO-1 and TNF-α and downregulation of GcLc, GR and TGF-ß by deletion of Nrf2 is specific to female mice. CONCLUSION: We conclude that Nrf2 provides protection in female mice against increase in BALF eosinophils, probably through down-regulation of proinflammatory cytokines/chemokines and upregulation of oxidative stress-related genes. The study also suggests lower susceptibility to lung tissue inflammation in female mice relative to their male counterparts and the synergistic effects of Nrf2 and exposure to ZnO-NPs on mRNA expression of GcLc, GR, HO-1, TGF-ß or TNF-α in female mice.
Subject(s)
Nanoparticles , Pneumonia , Zinc Oxide , Animals , Antioxidants/pharmacology , Cytokines/genetics , Cytokines/metabolism , Female , Glutathione Disulfide/metabolism , Glutathione Disulfide/toxicity , Inflammation/chemically induced , Inflammation/metabolism , Interleukin-6/metabolism , Lung , Male , Mice , NF-E2-Related Factor 2/genetics , NF-E2-Related Factor 2/metabolism , Nanoparticles/toxicity , Oxidative Stress , Pneumonia/chemically induced , Pneumonia/genetics , Pneumonia/metabolism , RNA, Messenger/metabolism , Rubber/metabolism , Rubber/toxicity , Sex Characteristics , Superoxide Dismutase-1/metabolism , Superoxide Dismutase-1/pharmacology , Transforming Growth Factor beta/metabolism , Tumor Necrosis Factor-alpha/metabolism , Zinc Oxide/metabolismABSTRACT
Various cancer cells require massive amounts of glucose as an energy source for their dysregulated growth. Although Dallose, a rare sugar, inhibits tumor cell growth via inhibition of glucose uptake, a few cells can survive after treatment. However, the mechanism by which Dalloseresistant cells are generated remains unclear. Here, we investigated the properties of Dalloseresistant cells and evaluated the efficacy of combined treatment with this rare sugar and antitumor drugs. To this end, we established a Dalloseresistant tumor cell line and prepared a C57BL/6J mouse tumor xenograft model using Lewis lung carcinoma (LLC) cells. Xenograftbearing mice were treated with Dallose (9 g/kg) and/or hydroxychloroquine (HCQ, 60 mg/kg), an autophagy inhibitor, for two weeks. Although Dallose inhibited LLC cell growth in a dosedependent manner, a few cells survived. The upregulation of LC3II, a classical autophagy marker, and the downregulation of mTOR and its downstream molecule Beclin1 were observed in established Dalloseresistant LLC cells, which were more sensitive to cell death induced by HCQ. Similarly, in the tumor xenograft model, the tumor volume in mice cotreated with Dallose and HCQ was considerably smaller than that in untreated or HCQtreated mice. Importantly, the administration of Dallose induced autophagy selectively at the tumor site of the xenograftbearing mice. These results provide a new therapeutic strategy targeting autophagy which is induced in tumor cells by Dallose administration, and may be used to improve therapies for lung cancer.
Subject(s)
Carcinoma, Lewis Lung , Hydroxychloroquine , Animals , Autophagy , Carcinoma, Lewis Lung/drug therapy , Carcinoma, Lewis Lung/metabolism , Cell Line, Tumor , Glucose , Humans , Hydroxychloroquine/pharmacology , Hydroxychloroquine/therapeutic use , Mice , Mice, Inbred C57BLABSTRACT
The enzyme kynurenine aminotransferase (KAT) catalyses the conversion of kynurenine (KYN) to kynurenic acid (KYNA). Although the isozymes KAT1-4 have been identified, KYNA is mainly produced by KAT2 in brain tissues. KNYA is an antagonist of N-methyl-D-aspartate and α-7-nicotinic acetylcholine receptors, and accumulation of KYNA in the brain has been associated with the pathology of schizophrenia. Therefore, KAT2 could be exploited as a therapeutic target for the management of schizophrenia. Although currently available KAT2 inhibitors irreversibly bind to pyridoxal 5'-phosphate (PLP), inhibition via this mechanism may cause adverse side effects because of the presence of other PLP-dependent enzymes. Therefore, we identified novel selective KAT2 inhibitors by screening approximately 13,000 molecules. Among these, glycyrrhizic acid (GL) and its analogues, glycyrrhetinic acid (GA) and carbenoxolone (CBX), were identified as KAT2 inhibitors. These compounds were highly selective for KAT2 and competed with its substrate KYN, but had no effects on the other 3 KAT isozymes. Furthermore, we demonstrated that in complex structures that were predicted in docking calculations, GL, GA and CBX were located on the same surface as the aromatic ring of KYN. These results indicate that GL and its analogues are highly selective and competitive inhibitors of KAT2.